Topic: Inflammatory bowel disease (IBD) in the U.S.

Inflammatory bowel disease in the U.S. - Statistics & Facts

Inflammatory bowel disease (IBD) refers to disorders that cause chronic inflammation of the digestive tract. The two most common types of IBD are Crohn’s disease and ulcerative colitis. IBD can be difficult to diagnose because symptoms are typical of other illnesses and diseases and can vary from person to person. Symptoms of IBD include diarrhea, stomach pain and cramping, bleeding ulcers, weight loss, and fatigue. A survey of patients with Crohn's disease in North America and Europe found that 56 percent had experienced tiredness/exhaustion/fatigue in the past month, while 53 percent had abdominal pain/cramps. Such symptoms were only slightly less common among patients with ulcerative colitis.

Number of adults aged 18 to 24 years with Crohn's disease or ulcerative colitis in the U.S.
*******

U.S. region with the highest percentage of people with Crohn's disease or ulcerative colitis
Northeast/South

Most common symptom among IBD patients in the U.S.
Fatigue

��徱�ٴǰ�’s Picks
��徱�ٴǰ�’s Picks
Current statistics on this topic

Diseases

Incidence of inflammatory bowel disease in the U.S. in 2015-2016, by ethnicity

Diseases

Mortality rate for IBD among older U.S. adults in 2017, by age

Therapy & Treatment

Strategies to cope with Crohn's flares reported by Crohn's patients in the U.S. 2019

Global overview

Projected IBD population in select countries in NA and Europe in 2010, 2020, and 2030
Projected IBD population in select countries in NA and Europe in 2010, 2020, and 2030
Projected prevalence of inflammatory bowel disease (IBD) in select countries in North America and Europe in 2010, 2020, and 2030
Most common Crohn's disease symptoms among Crohn's patients worldwide as of 2019
Most common Crohn's disease symptoms among Crohn's patients worldwide as of 2019
Percentage of Crohn's disease patients worldwide who reported select symptoms as of 2019*
Most common symptoms among ulcerative colitis patients worldwide in 2019
Most common symptoms among ulcerative colitis patients worldwide in 2019
Percentage of ulcerative colitis (UC) patients worldwide who reported select symptoms as of 2019
Severity of common symptoms of inflammatory bowel disease worldwide 2019
Severity of common symptoms of inflammatory bowel disease worldwide 2019
Percentage of patients with inflammatory bowel disease worldwide who reported symptoms were severe as of 2019
IBD patients worldwide discontinuing medication due to side effect concerns 2019
IBD patients worldwide discontinuing medication due to side effect concerns 2019
Percentage of IBD patients worldwide reporting discontinuing medication due to concerns about side effects as of 2019*

U.S. prevalence

Prevalence of inflammatory bowel disease in the U.S. in 2015-2016, by gender
Prevalence of inflammatory bowel disease in the U.S. in 2015-2016, by gender
Number of adults with Crohn's disease or ulcerative colitis in the U.S. in 2015-2016, by gender
Prevalence of inflammatory bowel disease in the U.S. in 2015-2016, by age
Prevalence of inflammatory bowel disease in the U.S. in 2015-2016, by age
Number of adults with Crohn's disease or ulcerative colitis in the U.S. in 2015-2016, by age
Incidence of inflammatory bowel disease in the U.S. in 2015-2016, by ethnicity
Incidence of inflammatory bowel disease in the U.S. in 2015-2016, by ethnicity
Percentage of adults with Crohn's disease or ulcerative colitis in the U.S. in 2015-2016, by ethnicity
Incidence of inflammatory bowel disease in the U.S. in 2015-2016, by region
Incidence of inflammatory bowel disease in the U.S. in 2015-2016, by region
Percentage of adults with Crohn's disease or ulcerative colitis in the U.S. in 2015-2016, by region

Symptoms and treatment

Quality of life measures among IBD patients in the U.S. as of 2018
Quality of life measures among IBD patients in the U.S. as of 2018
Percentage of U.S. adults with inflammatory bowel disease (IBD) who stated their IBD impacted their life in select ways as of 2018
IBD patients that experienced select IBD symptoms in the U.S. as of 2019
IBD patients that experienced select IBD symptoms in the U.S. as of 2019
Percentage of U.S. inflammatory bowel disease (IBD) patients that experienced select symptoms associated with IBD as of 2019
Severity and frequency of Crohn's disease symptoms among U.S. sufferers as of 2019
Severity and frequency of Crohn's disease symptoms among U.S. sufferers as of 2019
Severity and frequency of Crohn's disease symptoms reported by Crohn's patients in the U.S. as of 2019
Strategies used to improve IBD symptoms among U.S. respondents with IBD as of 2020
Strategies used to improve IBD symptoms among U.S. respondents with IBD as of 2020
Percentage of people with inflammatory bowel disease (IBD) in the United States who used select strategies to improve IBD symptoms as of 2020
Strategies to cope with Crohn's flares reported by Crohn's patients in the U.S. 2019
Strategies to cope with Crohn's flares reported by Crohn's patients in the U.S. 2019
Percentage of Crohn's patients in the United States who used select strategies to cope with flares as of 2019
Treatments used by IBD patients in the U.S. as of 2018
Treatments used by IBD patients in the U.S. as of 2018
Percentage of U.S. adults with inflammatory bowel disease (IBD) who used select treatments to manage their IBD as of 2018
Health care utilization among U.S. adults with IBD in 2015 and 2016
Health care utilization among U.S. adults with IBD in 2015 and 2016
Percentage of U.S. adults with inflammatory bowel disease (IBD) who utilized select health care resources in the past 12 months as of 2015-2016

Prevalence among older adults

Number of Medicare fee-for-service beneficiaries with inflammatory bowel disease 2018
Number of Medicare fee-for-service beneficiaries with inflammatory bowel disease 2018
Number of Medicare fee-for-service beneficiaries in the United States with Crohn's disease and ulcerative colitis in 2018
Share of Medicare fee-for-service beneficiaries with inflammatory bowel disease 2018
Share of Medicare fee-for-service beneficiaries with inflammatory bowel disease 2018
Share of Medicare fee-for-service beneficiaries in the United States with Crohn's disease and ulcerative colitis in 2018*
Share of Medicare beneficiaries with inflammatory bowel disease in 2018, by gender
Share of Medicare beneficiaries with inflammatory bowel disease in 2018, by gender
Share of Medicare fee-for-service beneficiaries in the United States with Crohn's disease and ulcerative colitis in 2018, by gender
Share of Medicare beneficiaries with inflammatory bowel disease in 2018, by age
Share of Medicare beneficiaries with inflammatory bowel disease in 2018, by age
Share of Medicare fee-for-service beneficiaries in the United States with Crohn's disease and ulcerative colitis in 2018, by age group
Share of Medicare beneficiaries with inflammatory bowel disease in 2018, by ethnicity
Share of Medicare beneficiaries with inflammatory bowel disease in 2018, by ethnicity
Share of Medicare fee-for-service beneficiaries in the United States with Crohn's disease and ulcerative colitis in 2018, by ethnicity

Hospitalizations among older adults

Hospitalizations for IBD among older U.S. adults in 2017, by gender
Hospitalizations for IBD among older U.S. adults in 2017, by gender
Number of hospitalizations for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by gender*
Hospitalizations for IBD among older U.S. adults in 2017, by age
Hospitalizations for IBD among older U.S. adults in 2017, by age
Number of hospitalizations for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by age*
Hospitalization rate for IBD among older U.S. adults in 2017, by gender
Hospitalization rate for IBD among older U.S. adults in 2017, by gender
Rate of hospitalizations for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by gender (per 100,000 enrollees)*
Hospitalization rate for IBD among older U.S. adults in 2017, by age
Hospitalization rate for IBD among older U.S. adults in 2017, by age
Rate of hospitalizations for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by age (per 100,000 enrollees)*
Length of hospital stays for IBD among older U.S. adults in 2017, by gender
Length of hospital stays for IBD among older U.S. adults in 2017, by gender
Average length of stay in hospital for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by gender (in days)*
Length of hospital stays for IBD among older U.S. adults in 2017, by age
Length of hospital stays for IBD among older U.S. adults in 2017, by age
Average length of stay in hospital for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by age (in days)*

Surgery and death among older adults

Surgery rate for IBD among older U.S. adults in 2017, by gender
Surgery rate for IBD among older U.S. adults in 2017, by gender
Rate of surgery for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by gender (per 100 hospital stays)*
Surgery rate for IBD among older U.S. adults in 2017, by age
Surgery rate for IBD among older U.S. adults in 2017, by age
Rate of surgery for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by age (per 100 hospital stays)*
Mortality rate for IBD among older U.S. adults in 2017, by gender
Mortality rate for IBD among older U.S. adults in 2017, by gender
30-day mortality rate for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by gender (per 100 hospital stays)*
Mortality rate for IBD among older U.S. adults in 2017, by age
Mortality rate for IBD among older U.S. adults in 2017, by age
30-day mortality rate for Crohn's disease and ulcerative colitis among Medicare fee-for-service beneficiaries in the U.S. in 2017, by age (per 100 hospital stays)*

Miscellaneous

Diagnostics used in the diagnosis of IBD patients in the U.S. as of 2018
Diagnostics used in the diagnosis of IBD patients in the U.S. as of 2018
Percentage of U.S. adults with inflammatory bowel disease that had select diagnostics tests for diagnosis as of 2018
U.S. adults with IBD and select chronic conditions in 2015-2016
U.S. adults with IBD and select chronic conditions in 2015-2016
Percentage of U.S. adults with inflammatory bowel disease and select chronic conditions in 2015-2016
Smoking prevalence among U.S. adults with IBD from 2015-2016
Smoking prevalence among U.S. adults with IBD from 2015-2016
Percentage of U.S. adults with inflammatory bowel disease who smoked in 2015-2016
Weight status of U.S. adults with IBD from 2015-2016
Weight status of U.S. adults with IBD from 2015-2016
Percentage of U.S. adults with inflammatory bowel disease who were overweight or obese in 2015 and 2016
U.S. adults with IBD under psychological distress from 2015-2016
U.S. adults with IBD under psychological distress from 2015-2016
Percentage of U.S. adults with inflammatory bowel disease who were under serious psychological distress from 2015-2016
Saving of U.S. costs through generic pharmaceuticals by condition 2024
Saving of U.S. costs through generic pharmaceuticals by condition 2024
Cost savings through generics in the United States in 2024, by major condition (in billion U.S. dollars)
Leading therapy areas by commercial PMPM spending U.S. 2022
Leading therapy areas by commercial PMPM spending U.S. 2022
Leading therapy areas in the U.S. by commercial PMPM spending in 2022 (in U.S. dollars)

Number of adults aged 18 to 24 years with Crohn's disease or ulcerative colitis in the U.S.
*******

U.S. region with the highest percentage of people with Crohn's disease or ulcerative colitis
Northeast/South

Most common symptom among IBD patients in the U.S.
Fatigue

Key figures

The most important key figures provide you with a compact summary of the topic of "Inflammatory bowel disease (IBD) in the U.S." and take you straight to the corresponding statistics.

- Share of U.S. Crohn's disease patients who experience symptoms 15+ days a month
- 49%
Log in or register to access full data.
Detailed statistics
Severity and frequency of Crohn's disease symptoms among U.S. sufferers as of 2019
- Share of U.S. IBD patients who have sleep problems
- 47%
Log in or register to access full data.
Detailed statistics
Quality of life measures among IBD patients in the U.S. as of 2018

- Number of Medicare fee-for-service beneficiaries with Crohn's disease
- 99,700
Log in or register to access full data.
Detailed statistics
Number of Medicare fee-for-service beneficiaries with inflammatory bowel disease 2018
- Share of female Medicare fee-for-service beneficiaries with ulcerative colitis
- .**%
Log in or register to access full data.
Detailed statistics
Share of Medicare beneficiaries with inflammatory bowel disease in 2018, by gender
- Share of Medicare fee-for-service beneficiaries aged 75 to 84 years with Crohn's disease
- .41%
Log in or register to access full data.
Detailed statistics
Share of Medicare beneficiaries with inflammatory bowel disease in 2018, by age

- Number of hospitalizations for Crohn's disease among Medicare fee-for-service beneficiaries aged 65 to 74 in 2017
- 2,912
Log in or register to access full data.
Detailed statistics
Hospitalizations for IBD among older U.S. adults in 2017, by age
- Number of hospitalizations for Crohn's disease among female Medicare fee-for-service beneficiaries in 2017
- 2,781
Log in or register to access full data.
Detailed statistics
Hospitalizations for IBD among older U.S. adults in 2017, by gender
- Average length of stay in hospital for Crohn's disease among Medicare fee-for-service beneficiaries
- 3.9 days
Log in or register to access full data.
Detailed statistics
Length of hospital stays for IBD among older U.S. adults in 2017, by gender

- Share of U.S. adults with IDB that had a colonoscopy for diagnosis
- 81%
Log in or register to access full data.
Detailed statistics
Diagnostics used in the diagnosis of IBD patients in the U.S. as of 2018
- Share of U.S. adults with IBD who were obese
- ****%
Log in or register to access full data.
Detailed statistics
Weight status of U.S. adults with IBD from 2015-2016
- Share of U.S. adults with IBD who were under serious psychological distress
- 7.4%
Log in or register to access full data.
Detailed statistics
U.S. adults with IBD under psychological distress from 2015-2016

Further reports

Get the best reports to understand your industry

Chronic obstructive pulmonary disease (COPD) in the U.S.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

��ƽ��

Inflammatory bowel disease in the U.S. - Statistics & Facts

Key insights